• STJ72608 (0. 1µg/ml) staining of Human Lymph Nodes lysate (35µg protein in RIPA buffer). Detected by chemiluminescence.
  • STJ72608 (0. 1µg/ml) staining of Human (A) , Mouse (B) and Rat (C) Spleen lysates (35µg protein in RIPA buffer). Detected by chemiluminescence.
  • STJ72608 (0. 3µg/ml) staining of Pig Spleen (A) and Pig Skeletal Muscle (B) lysates (35µg protein in RIPA buffer). Detected by chemiluminescence.

Anti-IDH3A antibody (C-Term) (STJ72608)

SKU:
STJ72608-100

Shipping:
Free Shipping
Current Stock:
Host: Goat
Applications: Pep-ELISA/WB/IHC
Reactivity: Human/Mouse/Rat/Dog/Pig/Cow
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Goat polyclonal antibody anti-IDH3A (C-Term) is suitable for use in ELISA, Western Blot and Immunohistochemistry research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA
Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration: 0.5 mg/mL
Dilution Range: IHC-3.75µg/ml
ELISA-antibody detection limit dilution 1:32000.
Storage Instruction: Store at-20°C on receipt and minimise freeze-thaw cycles.
Gene Symbol: IDH3A
Gene ID: 3419
Uniprot ID: IDH3A_HUMAN
Immunogen Region: C-Term
Accession Number: NP_005521.1
Immunogen Sequence: DFTEEICRRVKDLD
Protein Name Isocitrate Dehydrogenase Nad Subunit Alpha - Mitochondrial
Isocitric Dehydrogenase Subunit Alpha
Nad(+-Specific Icdh Subunit Alpha
Database Links Reactome: R-HSA-71403
Cellular Localisation Mitochondrion
Alternative Antibody Names Anti-Isocitrate Dehydrogenase Nad Subunit Alpha - Mitochondrial antibody
Anti-Isocitric Dehydrogenase Subunit Alpha antibody
Anti-Nad(+-Specific Icdh Subunit Alpha antibody
Anti-IDH3A antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance